Daily Media Digest December 20, 2022

Ottawa researcher probes impact of ketogenic diet on Type 2 diabetics
Capital Current
“Ottawa Heart Institute researchers are seeing the impact that very low levels of glucose have on the hormone-producing beta cells over time.”
TAGS: type 2 diabetes, ketogenic diet, insulin, University of Ottawa Heart Institute

Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration
McGill Newsroom
“Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide …”
TAGS: neurodegenerative conditions, The Neuro (Montreal Neurological Institute-Hospital), Université de Montréal

5 steps for tackling Canada’s long-term care crisis: It starts with valuing the well-being of workers
The Conversation
“Canada’s long-term care sector was hard hit by the COVID-19 pandemic. Rapidly climbing patient deaths, a lack of safety provisions coupled with already-precarious employment and difficult working conditions took its toll on the mental health of health-care workers.”
TAGS: mental health, long-term care, health care workers, COVID-19, Queen’s University

Myoblast Fusion Process Could Be Exploited for Regenerative Purposes
Technology Networks
“Now a discovery made at the Montreal Clinical Research Institute of Montreal (IRCM) opens the door to the development of targeted therapies. Published …”
TAGS: muscular dystrophy, myoblast, Montreal Clinical Research Institute of Montreal (IRCM), Université de Montréal

B.C. universities to receive $4.3 million for innovation research funding
Global News
“Four British Columbia universities will receive $4.3 million from a government research and innovation program to help fund projects in the fields of health, technology and natural resources.”
TAGS: funding, Canadian health research, Simon Fraser University

Alberta patients with previously untreatable inherited vision loss[1] now have access to gene therapy Luxturna®
“… President and CEO of the Canadian Organization for Rare Disorders (CORD). “We are hopeful this leadership will inspire other provinces.”
TAGS: vision loss, rare disorders, Novartis, Canadian Organization for Rare Disorders (CORD)